Literature DB >> 22339852

Extended access to cocaine self-administration results in reduced glutamate function within the medial prefrontal cortex.

Osnat M Ben-Shahar1, Karen K Szumlinski, Kevin D Lominac, Ami Cohen, Evan Gordon, Kyle L Ploense, Jeremy DeMartini, Nicholas Bernstein, Nicole M Rudy, Ahmad N Nabhan, Arianne Sacramento, Kelly Pagano, Giovanni A Carosso, Nick Woodward.   

Abstract

Previous studies have shown that brief access to cocaine yields an increase in D2 receptor binding in the medial prefrontal cortex (mPFC), but that extended access to cocaine results in normalized binding of D2 receptors (i.e. the D2 binding returned to control levels). Extended-access conditions have also been shown to produce increased expression of the NR2 subunit of the N-Methyl-D-aspartate receptor in the mPFC. These results implicate disrupted glutamate and dopamine function within this area. Therefore, in the present study, we monitored glutamate and dopamine content within the mPFC during, or 24 hours after, cocaine self-administration in animals that experienced various amounts of exposure to the drug. Naïve subjects showed decreased glutamate and increased dopamine levels within the mPFC during cocaine self-administration. Exposure to seven 1-hour daily cocaine self-administration sessions did not alter the response to self-administered cocaine, but resulted in decreased basal dopamine levels. While exposure to 17 1-hour sessions also resulted in reduced basal dopamine levels, these animals showed increased dopaminergic, but completely diminished glutamatergic, response to self-administered cocaine. Finally, exposure to 17 cocaine self-administration sessions, the last 10 of which being 6-hour sessions, resulted in diminished glutamatergic response to self-administered cocaine and reduced basal glutamate levels within the mPFC while normalizing (i.e. causing a return to control levels) both the dopaminergic response to self-administered cocaine as well as basal dopamine levels within this area. These data demonstrate directly that the transition to escalated cocaine use involves progressive changes in dopamine and glutamate function within the mPFC.
© 2012 The Authors, Addiction Biology © 2012 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22339852      PMCID: PMC3360114          DOI: 10.1111/j.1369-1600.2011.00428.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  51 in total

1.  Drug abusers show impaired performance in a laboratory test of decision making.

Authors:  S Grant; C Contoreggi; E D London
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

2.  D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex.

Authors:  T Abekawa; T Ohmori; K Ito; T Koyama
Journal:  Brain Res       Date:  2000-06-09       Impact factor: 3.252

3.  Long-term frontal brain metabolic changes in cocaine abusers.

Authors:  N D Volkow; R Hitzemann; G J Wang; J S Fowler; A P Wolf; S L Dewey; L Handlesman
Journal:  Synapse       Date:  1992-07       Impact factor: 2.562

Review 4.  The somatic marker hypothesis and the possible functions of the prefrontal cortex.

Authors:  A R Damasio
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1996-10-29       Impact factor: 6.237

5.  Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization.

Authors:  B A Sorg; N Li; W R Wu
Journal:  J Pharmacol Exp Ther       Date:  2001-05       Impact factor: 4.030

Review 6.  Quantitative approaches to in vivo brain microdialysis.

Authors:  L H Parsons; J B Justice
Journal:  Crit Rev Neurobiol       Date:  1994

Review 7.  Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli.

Authors:  J D Jentsch; J R Taylor
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

8.  Relationship between subjective effects of cocaine and dopamine transporter occupancy.

Authors:  N D Volkow; G J Wang; M W Fischman; R W Foltin; J S Fowler; N N Abumrad; S Vitkun; J Logan; S J Gatley; N Pappas; R Hitzemann; C E Shea
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

9.  Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage.

Authors:  E T Rolls; J Hornak; D Wade; J McGrath
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

10.  Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.

Authors:  Avi E Zayara; Gregor McIver; Paola N Valdivia; Kevin D Lominac; Andrew C McCreary; Karen K Szumlinski
Journal:  Psychopharmacology (Berl)       Date:  2010-09-03       Impact factor: 4.530

View more
  22 in total

1.  Imbalances in prefrontal cortex CC-Homer1 versus CC-Homer2 expression promote cocaine preference.

Authors:  Alexis W Ary; Kevin D Lominac; Melissa G Wroten; Amy R Williams; Rianne R Campbell; Osnat Ben-Shahar; Georg von Jonquieres; Matthias Klugmann; Karen K Szumlinski
Journal:  J Neurosci       Date:  2013-05-08       Impact factor: 6.167

2.  Short and long access to cocaine self-administration activates tyrosine phosphatase STEP and attenuates GluN expression but differentially regulates GluA expression in the prefrontal cortex.

Authors:  Wei-Lun Sun; Agnieszka Zelek-Molik; Jacqueline F McGinty
Journal:  Psychopharmacology (Berl)       Date:  2013-04-27       Impact factor: 4.530

Review 3.  Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.

Authors:  Wendy J Lynch; Alexis B Peterson; Victoria Sanchez; Jean Abel; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2013-06-24       Impact factor: 8.989

4.  Cocaine-elicited imbalances in ventromedial prefrontal cortex Homer1 versus Homer2 expression: implications for relapse.

Authors:  Adam T Gould; Arianne D Sacramento; Melissa G Wroten; Bailey W Miller; Georg von Jonquieres; Matthias Klugmann; Osnat Ben-Shahar; Karen K Szumlinski
Journal:  Addict Biol       Date:  2013-09-30       Impact factor: 4.280

5.  The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators.

Authors:  Christina Gobin; Marek Schwendt
Journal:  Psychopharmacology (Berl)       Date:  2019-08-24       Impact factor: 4.530

6.  Effects of intra-accumbal administration of dopamine and ionotropic glutamate receptor drugs on delay discounting performance in rats.

Authors:  Justin R Yates; Michael T Bardo
Journal:  Behav Neurosci       Date:  2017-10       Impact factor: 1.912

7.  Verification of a genetic locus for methamphetamine intake and the impact of morphine.

Authors:  Emily C Eastwood; Amy J Eshleman; Aaron Janowsky; Tamara J Phillips
Journal:  Mamm Genome       Date:  2017-11-10       Impact factor: 2.957

8.  PI3K activation within ventromedial prefrontal cortex regulates the expression of drug-seeking in two rodent species.

Authors:  Karen K Szumlinski; Alexis W Ary; Christina B Shin; Melissa G Wroten; Justin Courson; Bailey W Miller; Micaela Ruppert-Majer; John W Hiller; John R Shahin; Osnat Ben-Shahar; Tod E Kippin
Journal:  Addict Biol       Date:  2018-11-18       Impact factor: 4.280

9.  Homer2 within the nucleus accumbens core bidirectionally regulates alcohol intake by both P and Wistar rats.

Authors:  Arshad Haider; Nicholas C Woodward; Kevin D Lominac; Arianne D Sacramento; Matthias Klugmann; Richard L Bell; Karen K Szumlinski
Journal:  Alcohol       Date:  2015-07-21       Impact factor: 2.405

10.  Prefrontal glutamate correlates of methamphetamine sensitization and preference.

Authors:  Kevin D Lominac; Sema G Quadir; Hannah M Barrett; Courtney L McKenna; Lisa M Schwartz; Paige N Ruiz; Melissa G Wroten; Rianne R Campbell; Bailey W Miller; John J Holloway; Katherine O Travis; Ganesh Rajasekar; Dan Maliniak; Andrew B Thompson; Lawrence E Urman; Tod E Kippin; Tamara J Phillips; Karen K Szumlinski
Journal:  Eur J Neurosci       Date:  2016-02-22       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.